Published in Biochemistry on June 01, 1999
Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. J Am Chem Soc (2004) 3.74
Stability and kinetics of G-quadruplex structures. Nucleic Acids Res (2008) 2.75
Not so crystal clear: the structure of the human telomere G-quadruplex in solution differs from that present in a crystal. Nucleic Acids Res (2005) 2.57
Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics. J Am Chem Soc (2003) 2.52
Genomic distribution and functional analyses of potential G-quadruplex-forming sequences in Saccharomyces cerevisiae. Nucleic Acids Res (2007) 1.98
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci U S A (2001) 1.48
Structural insights into G-quadruplexes: towards new anticancer drugs. Future Med Chem (2010) 1.44
Formation pathways of a guanine-quadruplex DNA revealed by molecular dynamics and thermodynamic analysis of the substates. Biophys J (2003) 1.38
Molecular dynamics simulations of Guanine quadruplex loops: advances and force field limitations. Biophys J (2004) 1.33
Energetics and kinetics of a conformational switch in G-quadruplex DNA. J Phys Chem B (2009) 1.29
Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res (2001) 1.22
Two-repeat Tetrahymena telomeric d(TGGGGTTGGGGT) Sequence interconverts between asymmetric dimeric G-quadruplexes in solution. J Mol Biol (2004) 1.19
Therapeutic strategies to inhibit MYC. Cold Spring Harb Perspect Med (2014) 1.19
Human telomeric G-quadruplex: thermodynamic and kinetic studies of telomeric quadruplex stability. FEBS J (2009) 1.15
Interaction of human telomeric DNA with N-methyl mesoporphyrin IX. Nucleic Acids Res (2012) 1.11
Interaction of human DNA topoisomerase I with G-quartet structures. Nucleic Acids Res (2000) 1.09
Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA. Nucleic Acids Res (2007) 1.02
Tetramethylpyridiniumporphyrazines--a new class of G-quadruplex inducing and stabilising ligands. Chem Commun (Camb) (2006) 1.02
Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation. Nucleic Acids Res (2007) 0.97
G-quartets assembly within a G-rich DNA flap. A possible event at the center of the HIV-1 genome. Nucleic Acids Res (2002) 0.97
Molecular dynamics of DNA quadruplex molecules containing inosine, 6-thioguanine and 6-thiopurine. Biophys J (2001) 0.95
Use of competition dialysis in the discovery of G-quadruplex selective ligands. Methods (2007) 0.93
Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. Biochimie (2008) 0.91
DNA and the chromosome - varied targets for chemotherapy. Cell Chromosome (2004) 0.88
Interactions of a platinum-modified perylene derivative with the human telomeric G-quadruplex. J Phys Chem B (2011) 0.81
Interactions of actinomycin D with human telomeric G-quadruplex DNA. Biochemistry (2009) 0.80
Chiral ruthenium(II) polypyridyl complexes: stabilization of g-quadruplex DNA, inhibition of telomerase activity and cellular uptake. PLoS One (2012) 0.78
Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem (1997) 2.66
G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol Sci (2000) 1.94
Selective interactions of cationic porphyrins with G-quadruplex structures. J Am Chem Soc (2001) 1.91
A DNA polymerase stop assay for G-quadruplex-interactive compounds. Nucleic Acids Res (1999) 1.68
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res (1999) 1.63
Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J Biol Chem (2000) 1.54
Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J Med Chem (1999) 1.48
NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry (1998) 1.45
Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. Science (1984) 1.44
Effect of DNA secondary structure on human telomerase activity. Biochemistry (1998) 1.43
Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry (1985) 1.37
Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem (2001) 1.28
Sequence selectivity of DNA covalent modification. Chem Res Toxicol (1992) 1.28
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs. Biochemistry (1986) 1.12
Mechanism of interaction of CC-1065 (NSC 298223) with DNA. Cancer Res (1982) 1.11
Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos. Anticancer Drug Des (1999) 1.11
Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot (Tokyo) (1977) 1.10
Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B. Biochemistry (1981) 1.07
Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics. Biochemistry (1993) 1.07
The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic. J Antibiot (Tokyo) (1986) 1.02
Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther (2001) 1.00
Thermally induced DNA.RNA hybrid to G-quadruplex transitions: possible implications for telomere synthesis by telomerase. Biochemistry (1996) 1.00
Regulation of catalytic activity and processivity of human telomerase. Biochemistry (1999) 1.00
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic 11-demethyltomaymycin and its biologically inactive metabolite oxotomaymycin by Streptomyces achromogenes. Biochemistry (1976) 0.99
Proposed structure of the anthramycin-DNA adduct. Nature (1979) 0.99
Telomerase assay using biotinylated-primer extension and magnetic separation of the products. Biotechniques (1998) 0.98
Structure of the (+)-CC-1065-DNA adduct: critical role of ordered water molecules and implications for involvement of phosphate catalysis in the covalent reaction. Biochemistry (1991) 0.97
TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin. Chem Biol (1995) 0.96
Inhibition of unwinding of G-quadruplex structures by Sgs1 helicase in the presence of N,N'-bis[2-(1-piperidino)ethyl]-3,4,9,10-perylenetetracarboxylic diimide, a G-quadruplex-interactive ligand. Biochemistry (2000) 0.95
Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J Med Chem (1995) 0.95
Molecular struggle for transcriptional control. Nat Med (1995) 0.93
Biosynthesis of anthramycin. Determination of the labeling pattern by the use of radioactive and stable isotope techniques. J Am Chem Soc (1975) 0.93
The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA. Biochemistry (1992) 0.92
Telomere maintenance mechanisms as a target for drug development. Oncogene (2000) 0.92
Structure of a covalent DNA minor groove adduct with a pyrrolobenzodiazepine dimer: evidence for sequence-specific interstrand cross-linking. J Med Chem (1994) 0.90
Pyrrolo[1,4]benzodiazepine antitumor antibiotics: evidence for two forms of tomaymycin bound to DNA. Biochemistry (1986) 0.90
Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules. Biochim Biophys Acta (1977) 0.90
Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii. J Biol Chem (1999) 0.88
Cationic porphyrins promote the formation of i-motif DNA and bind peripherally by a nonintercalative mechanism. Biochemistry (2000) 0.88
Demonstration of a C-methylating enzyme in cell free extracts of indolmycin-producing Streptomyces griseus. Biochem Biophys Res Commun (1970) 0.87
Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites. Proc Natl Acad Sci U S A (1998) 0.87
Differential rates of reversibility of ecteinascidin 743-DNA covalent adducts from different sequences lead to migration to favored bonding sites. J Am Chem Soc (2001) 0.86
Characterization of a 12-mer duplex d(GGCGGAGTTAGG).d(CCTAACTCCGCC) containing a highly reactive (+)-CC-1065 sequence by 1H and 31P NMR, hydroxyl-radical footprinting, and NOESY restrained molecular dynamics calculations. Chem Res Toxicol (1992) 0.85
Protection against anthramycin-induced toxicity in mice by coenzyme Q10. J Natl Cancer Inst (1980) 0.85
(+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting. Nucleic Acids Res (1993) 0.85
(+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts. Chem Res Toxicol (1991) 0.85
Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry (1994) 0.85
Pyrrolo (1,4) benzodiazepine antitumor antibiotics: Biosynthetic studies on the conversion of tryptophan to the anthranilic acid moieties of sibiromycin and tomaymycin. Antimicrob Agents Chemother (1979) 0.84
Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell. J Biol Chem (1982) 0.84
Biosynthesis of indoleisopropionic acid by Claviceps. Biological C-methylation involving an intact methyl group. Arch Biochem Biophys (1969) 0.84
Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage. J Biol Chem (1998) 0.84
The biosynthesis of indolmycin. J Am Chem Soc (1971) 0.83
Structural distortions induced by integration host factor (IHF) at the H' site of phage lambda probed by (+)-CC-1065, pluramycin, and KMnO4 and by DNA cyclization studies. Biochemistry (1996) 0.83
Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA. Chem Res Toxicol (1992) 0.82
Effect of the (+)-CC-1065-(N3-adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymerase. Biochemistry (1992) 0.82
Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065. Biochemistry (1986) 0.82
Demonstration of the asymmetric effect of CC-1065 on local DNA structure using a site-directed adduct in a 117-base-pair fragment from M13mp1. Proc Natl Acad Sci U S A (1987) 0.82
Characterization of a unique tomaymycin-d(CICGAATTCICG)2 adduct containing two drug molecules per duplex by NMR, fluorescence, and molecular modeling studies. Biochemistry (1990) 0.82
A-tract and (+)-CC-1065-induced bending of DNA. Comparison of structural features using non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR. Biochemistry (1993) 0.82
DNA as a target for drug action. Trends Pharmacol Sci (1988) 0.82
A model for the T-antigen-induced structural alteration of the SV40 replication origin based upon experiments with specific probes for bent, straight, and unwound DNA. Biochemistry (1996) 0.82
Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA. Anticancer Drug Des (1992) 0.81
Regulation of antibiotic production: catabolite inhibition and the dualistic effect of glucose on indolmycin production. J Antibiot (Tokyo) (1974) 0.81
Targeting telomeres and telomerase. Methods Enzymol (2001) 0.81
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthetic conversion of tyrosine to the C2- and C3-proline moieties of anthramycin, tomaymycin, and sibiromycin. Biochemistry (1979) 0.81
Recognition and repair of the CC-1065-(N3-adenine)-DNA adduct by the UVRABC nucleases. Biochemistry (1988) 0.80
Accurate determination of quadruplex binding affinity and potency of G-quadruplex-interactive telomerase inhibitors by use of a telomerase extension assay requires varying the primer concentration. Anticancer Drug Des (1999) 0.80
Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex. Nucleic Acids Res (1984) 0.80
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic sibiromycin by Streptosporangium sibiricum. Biochemistry (1979) 0.80
Synthesis and biochemical evaluation of the CBI-PDE-I-dimer, a benzannelated analog of (+)-CC-1065 that also produces delayed toxicity in mice. J Med Chem (1993) 0.80
Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment. Biochemistry (1986) 0.80
Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA. Biochemistry (1993) 0.80
Molecular approaches to achieving control of gene expression by drug intervention at the transcriptional level. Anticancer Drug Des (1999) 0.80
Binding of Sp1 to the 21-bp repeat region of SV40 DNA: effect of intrinsic and drug-induced DNA bending between GC boxes. Gene (1994) 0.79
Isolation and absolute configuration of indolmycenic acid, an intermediate in the biosynthesis of indolmycin by Streptomyces griseus. Tetrahedron Lett (1970) 0.79
Biosynthesis of the antitumor antibiotic CC-1065 by Streptomyces zelensis. J Antibiot (Tokyo) (1983) 0.78
Template-directed design of a DNA-DNA cross-linker based upon a bis-tomaymycin-duplex adduct. J Med Chem (1992) 0.78
Determination of the major tautomeric form of the covalently modified adenine in the (+)-CC-1065-DNA adduct by 1H and 15N NMR studies. Biochemistry (1990) 0.78
Alkylation of guanine and cytosine in DNA by bizelesin. Evidence for a covalent immobilization leading to a proximity-driven alkylation of normally unreactive bases by a (+)-CC-1065 cross-linking compound. Chem Res Toxicol (1994) 0.78
In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug. Cancer Res (1979) 0.78
Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model. J Med Chem (1998) 0.77
The reaction of anthramycin with DNA. Proton and carbon nuclear magnetic resonance studies on the structure of the anthramycin-DNA adduct. J Biol Chem (1984) 0.77
Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA. J Med Chem (1992) 0.77
DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065. Anticancer Drug Des (1991) 0.77
Repair of helix-stabilizing anthramycin-N2 guanine DNA adducts by UVRA and UVRB proteins. J Mol Biol (1991) 0.77
Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent. J Am Chem Soc (2001) 0.76
Coenzyme Q10 or alpha-tocopherol reduce the acute toxicity of anthramycin in mice. Res Commun Chem Pathol Pharmacol (1979) 0.76
Chemical conversion of anthramycin 11-methyl ether to didehydroanhydroanthramycin and its utilization in studies of the biosynthesis and mechanism of action of anthramycin. J Nat Prod (1981) 0.76
Sensitivity and permeability of the anthramycin producing organism Streptomyces refuineus to anthramycin and structurally related antibiotics. J Antibiot (Tokyo) (1981) 0.75
The quinobenzoxazines: relationship between DNA binding and biological activity. Anticancer Drug Des (1999) 0.75
Anthramycin binding to deoxyribonucleic acid-mitomycin C complexes. Evidence for drug-induced deoxyribonucleic acid conformational change and cooperativity in mitomycin C binding. Biochemistry (1981) 0.75
Molecular biology and medicinal chemistry. J Med Chem (1987) 0.75
Application of long-range spin-spin couplings in biosynthetic studies. J Org Chem (1976) 0.75
Solution conformation of a bizelesin A-tract duplex adduct: DNA-DNA cross-linking of an A-tract straightens out bent DNA. J Mol Biol (1995) 0.75
Pathways of DNA repair operating in yeast treated with the pyrrolo(1,4)-benzodiazepine antitumor antibiotics. J Antibiot (Tokyo) (1978) 0.75
Mutagenic and recombinogenic effects of the antitumor antibiotic anthramycin. Cancer Res (1978) 0.75
DNA binding, induction of unscheduled DNA synthesis, and excision of anthramycin from DNA in normal and repair-deficient human fibroblasts. J Biol Chem (1979) 0.75